EarningsQ4 2018 Earnings Report

Outlook Therapeutics (41O) Q4 2018 Earnings Report

8 Followers

DE:41O Q4 2018 EPS Results

Actual EPS-€0.28

Consensus EPS―

Beat/Miss―

One Year Ago EPS-€2.13

Actual Revenue€677.65K

Expected Revenue―

Beat/Miss―

YoY Revenue Growth―

QuarterQ4 2018

Date12/18/2018

TimeTBA

Conference CallTuesday, December 18, 2018

DE:41O Upcoming Earnings

Outlook Therapeutics's next earnings date is estimated for December 18, 2026, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Dec 18, 2026	2026 (Q4)	-0.06 / -	-0.053	―
Aug 14, 2026	2026 (Q3)	-0.07 / -0.08	-0.386	79.55% (+0.31)
May 15, 2026	2026 (Q2)	-0.11 / -0.14	-0.351	60.00% (+0.21)
Feb 17, 2026	2026 (Q1)	-0.20 / -0.19	-0.781	75.28% (+0.59)
Dec 19, 2025	2025 (Q4)	-0.23 / -0.05	-0.773	93.18% (+0.72)
Aug 14, 2025	2025 (Q3)	-0.31 / -0.39	-0.729	46.99% (+0.34)
May 15, 2025	2025 (Q2)	-0.48 / -0.35	-1.361	74.19% (+1.01)
Feb 14, 2025	2025 (Q1)	-0.67 / -0.78	-0.702	-11.25% (-0.08)
Dec 27, 2024	2024 (Q4)	-0.70 / -0.77	-0.878	12.00% (+0.11)
Aug 14, 2024	2024 (Q3)	-0.91 / -0.73	-1.405	48.13% (+0.68)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed